Stock Traders Buy Large Volume of Leap Therapeutics Call Options (NASDAQ:LPTX)

Leap Therapeutics, Inc. (NASDAQ:LPTX) was the target of some unusual options trading activity on Thursday. Stock traders acquired 5,907 call options on the company. This is an increase of 546% compared to the average daily volume of 914 call options.

Leap Therapeutics Stock Performance

Shares of NASDAQ:LPTX traded up $1.61 during trading on Thursday, hitting $2.05. The company’s stock had a trading volume of 760,562,526 shares.

Leap Therapeutics Company Profile

Leap Therapeutics, Inc, a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers.